1. Risk factors for nontuberculous mycobacterial isolation in patients with cystic fibrosis: A meta‐analysis
- Author
-
Raphaele Nove-Josserand, Stéphane Durupt, Pierre-Régis Burgel, Zoe Cavalli, Philippe Reix, Isabelle Durieu, Quitterie Reynaud, and Romain Bricca
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Cystic Fibrosis ,Mycobacterium Infections, Nontuberculous ,medicine.disease_cause ,Azithromycin ,Cystic fibrosis ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,030225 pediatrics ,Internal medicine ,Humans ,Medicine ,biology ,business.industry ,Nontuberculous Mycobacteria ,Odds ratio ,bacterial infections and mycoses ,biology.organism_classification ,medicine.disease ,Confidence interval ,Stenotrophomonas maltophilia ,030228 respiratory system ,Staphylococcus aureus ,Meta-analysis ,Pediatrics, Perinatology and Child Health ,Nontuberculous mycobacteria ,business ,medicine.drug - Abstract
BACKGROUND To better understand the mechanisms of infection with nontuberculous mycobacteria (NTM) in patients with cystic fibrosis (CF), we explore different risk factors associated with NTM positivity in a meta-analysis. METHODS Studies published before 31 July 2019 were selected from MEDLINE. Combined odds ratios (ORs) were calculated by pooling the ORs of each study. The weighted mean difference (WMD) was used for continuous numerical measurements. Summary data were pooled using fixed- or random-effects models according to the presence of heterogeneity (P 50%). RESULTS Nineteen studies with a total of 23 418 patients, of whom 1421 (6%) were diagnosed as NTM positive, were included. Older age was significantly associated with NTM positivity (WMD = 2.12, 95% confidence interval [CI]: 1.11-3.13; P
- Published
- 2020
- Full Text
- View/download PDF